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Background: Imaging the cardiac nervous system in heart failure (HF) with 123-I metaiodobenzylguanidine (MIBG) has emerged as a new 
prognostic tool in patients evaluated for cardiac defibrillator. Diabetic (DM) patients with HF show lower cardiac sympathetic actitvity than non-DM. 
Therefore we assess whether the presence of DM influence the progostic utility of cardiac MIBG imaging in this scenario.
Methods: Seventy-eight patients with HF and severe left ventricular dysfunction undergoing evaluation for ICD implantation were prospectively 
enrolled. Cardiac 123I-MIBG imaging with calculation of early and late heart to mediastinum (H/M) ratios and cardiac washout rate to assess 
cardiac innervation was performed. The primary endpoint was death, HF hospitalizations, appropriate ICD discharge or symptomatic ventricular 
tachycardia. The secondary endpoint was death and arrhythmic events.
results: During a mean follow-up of 19.5 months, 24 and 16 patients reached the primary and secondary endpoint, respectively. DM and non-DM 
patients with late H/M ratio ≤ 1.30 showed significantly more cardiac events. In multivariate Cox proportional hazards analysis, late H/M ratio ≤ 
1.30 was an independent predictor of primary (HR 5.82; 95% IC: 2.21-15.30; p<0.001) and secondary endpoint (HR 6.48; 95% IC: 1.98-21.18; 
p=0,002).
conclusion: Late H/M ratio ≤ 1.30 was a predictor of cardiac and arrhythmic events in both DM and non-DM patients with severe HF evaluated 
for primary prevention ICD implantation.
 
